Outlook Therapeutics, Inc. (OTLK)

1d ago, source: Yahoo Finance

ISELIN, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of ...

Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million

9d ago, source:

Pursuant to the securities purchase agreement entered into on January 24, 2024, Outlook Therapeutics issued to Syntone an aggregate of 714,286 shares of common stock and accompanying warrants to ...

Outlook Therapeutics Stock (NASDAQ:OTLK), Analyst Ratings, Price Targets, Predictions

28d ago, source: Benzinga.com

$8.18-38.88% HC Wainwright & Co.

Viking Therapeutics Reports Q1 Results: 'An Exceptional Period' Says CEO

10m ago, source: Hosted on MSN

Viking Therapeutics, Inc. (NASDAQ:VKTX) reported its first-quarter financial ... Boeing Isn't Junk Status — Yet: Moody's ...

Viking Therapeutics Reports First Quarter 2024 Results: Aligns with Analyst Projections

1h ago, source:

Net Loss: Reported a net loss of $27.4 million for Q1 2024, slightly below the estimated net loss of $28.07 million. Earnings Per Share (EPS): Recorded a loss of $0.26 per share, surpassing the ...

Outlook Therapeutics, Inc. (41O.F)

21d ago, source: Yahoo Finance

Positive opinion serves as a basis for final decision for potential authorization from the European Commission (EC), expected within 67 days ISELIN, N.J., March 22, 2024 (GLOBE NEWSWIRE) -- Outlook ...

Buy Rating Reaffirmed for Repare Therapeutics on Strong Clinical Outlook and Attractive Valuation

3d ago, source:

Analyst David Martin PhD of Bloom Burton maintained a Buy rating on Repare Therapeutics (RPTX – Research Report), retaining the price ...

Spero Therapeutics Delivers On Game Plan To Create Shareholder Value

1d ago, source:

Spero has excellent downside protection and additional upside from the payments from the Tebipenem HBr deal with GSK. Learn ...

Outlook Therapeutics Inc OTLK

2d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Outlook Therapeutics Inc OTLK

2d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Outlook Therapeutics Inc.

27d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

OUTLOOK THERAPEUTICS INC (OTLK)

22d ago, source: Investing

On Wednesday, Outlook Therapeutics Inc. (NASDAQ: NASDAQ:OTLK) received an upgrade from BTIG, moving from a Neutral to a Buy rating, with a new price target set at $50.00. The ...